Monitored anesthesia care with remimazolam for gynecological day surgeries: Case reports

Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery.

Detalles Bibliográficos
Autores principales: Choi, So Ron, Kim, Tae Hyung, Eom, Deuk Won, Jung, Ji Wook, Park, Sang Yoong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640626/
https://www.ncbi.nlm.nih.gov/pubmed/36381036
http://dx.doi.org/10.1002/ccr3.6536
Descripción
Sumario:Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery.

Ejemplares similares